News & Press Releases

All
  • All
  • Blog
  • Bowel Cancer
  • Case Study
  • Chemotoxicity
  • Colorectal Cancer
  • News
  • Personalised Medicine
  • Press Release
Ai Award Winner Small 2

PRESS RELEASE: Oxford Cancer Biomarkers closes funding round led by Plutus Investment Group LLP

Ai Award Winner Small 2

PRESS RELEASE: OncoHelix and Oxford Cancer Biomarkers Enter into a Partnership to Offer Breakthrough Cancer Genetic Screening Test to Canadians

Ai Award Winner Small 2

PRESS RELEASE: Oxford Cancer Biomarkers granted Artificial Intelligence in Health and Care Award

PRESS RELEASE: Oxford Cancer Biomarkers announces European expansion of life-saving chemotherapy toxicity test and independent, real-world evidence of patient benefit

PRESS RELEASE: Oxford Cancer Biomarkers appoints Joanna Smart as Chair of the Board

Health Economics model for OncoProg® commissioned

Ocb Oncoprog Master Logo Rgb White

PRESS RELEASE: OncoProg receives CE mark

PRESS RELEASE: Kyoung Mee Lee joins our Board of Directors

ColoProg becomes OncoProg

ToxNav ® validation data published

Istock 953932714

HAPB3 joins the ToxNav panel

Graph

Colorectal cancer in the Covid-19 era